TIDMGSK

RNS Number : 9373B

GlaxoSmithKline PLC

15 January 2018

GlaxoSmithKline plc (the 'Company')

Transaction notification

 
 1.   Details of PDMR/person closely associated 
       with them ('PCA') 
===  ========================================================= 
 a)   Name                   Ms E Walmsley 
===  ======================  ================================= 
 b)   Position/status        Chief Executive Officer 
===  ======================  ================================= 
 c)   Initial notification/  Initial notification 
       amendment 
===  ======================  ================================= 
 2.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
===  ========================================================= 
 a)   Name                   GlaxoSmithKline plc 
===  ======================  ================================= 
 b)   LEI                    5493000HZTVUYLO1D793 
===  ======================  ================================= 
 3.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transaction(s) 
       has been conducted 
===  ========================================================= 
 a)   Description             Ordinary shares of 25 pence each 
       of the financial        ('Ordinary Shares') 
       instrument              ISIN: GB0009252882 
===  ======================  ================================= 
 b)   Nature of              Acquisition of Ordinary Shares 
       the transaction        following the re-investment of 
                              dividends paid to shareholders 
                              on 11 January 2018. 
===  ======================  ================================= 
 c)   Price(s) and             Price(s)      Volume(s) 
       volume(s)               ------------  ---------- 
                                GBP13.3440    473.274 
                               ------------  ---------- 
===  ======================  ================================= 
 d)   Aggregated             n/a (single transaction) 
       information 
       Aggregated 
       volume Price 
===  ======================  ================================= 
 e)   Date of the            2018-01-11 
       transaction 
===  ======================  ================================= 
 f)   Place of the           London Stock Exchange (XLON) 
       transaction 
===  ======================  ================================= 
 
 
 1.   Details of PDMR/person closely associated 
       with them ('PCA') 
===  ======================================================== 
 a)   Name                   Mr R G Connor 
===  ======================  ================================ 
 b)   Position/status        President, Global Manufacturing 
                              & Supply 
===  ======================  ================================ 
 c)   Initial notification/  Initial notification 
       amendment 
===  ======================  ================================ 
 2.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
===  ======================================================== 
 a)   Name                   GlaxoSmithKline plc 
===  ======================  ================================ 
 b)   LEI                    5493000HZTVUYLO1D793 
===  ======================  ================================ 
 3.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transaction(s) 
       has been conducted 
===  ======================================================== 
 a)   Description            Ordinary shares of 25 pence each 
       of the financial       ('Ordinary Shares') 
       instrument             ISIN: GB0009252882 
===  ======================  ================================ 
 b)   Nature of              Acquisition of Ordinary Shares 
       the transaction        following the re-investment of 
                              dividends paid to shareholders 
                              on 11 January 2018. 
===  ======================  ================================ 
 c)   Price(s) and             Price(s)      Volume(s) 
       volume(s)               ------------  ---------- 
                                GBP13.3440    82.400 
                               ------------  ---------- 
===  ======================  ================================ 
 d)   Aggregated             n/a (single transaction) 
       information 
       Aggregated 
       volume Price 
===  ======================  ================================ 
 e)   Date of the            2018-01-11 
       transaction 
===  ======================  ================================ 
 f)   Place of the           London Stock Exchange (XLON) 
       transaction 
===  ======================  ================================ 
 
 
 1.   Details of PDMR/person closely associated 
       with them ('PCA') 
===  ========================================================= 
 a)   Name                   Mr L Debruyne 
===  ======================  ================================= 
 b)   Position/status        President, Global Vaccines 
===  ======================  ================================= 
 c)   Initial notification/  Initial notification 
       amendment 
===  ======================  ================================= 
 2.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
===  ========================================================= 
 a)   Name                   GlaxoSmithKline plc 
===  ======================  ================================= 
 b)   LEI                    5493000HZTVUYLO1D793 
===  ======================  ================================= 
 3.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transaction(s) 
       has been conducted 
===  ========================================================= 
 a)   Description             Ordinary shares of 25 pence each 
       of the financial        ('Ordinary Shares') 
       instrument              ISIN: GB0009252882 
===  ======================  ================================= 
 b)   Nature of              Acquisition of Ordinary Shares 
       the transaction        following the re-investment of 
                              dividends paid to shareholders 
                              on 11 January 2018. 
===  ======================  ================================= 
 c)   Price(s) and             Price(s)      Volume(s) 
       volume(s)               ------------  ---------- 
                                GBP13.3440    851.563 
                               ------------  ---------- 
===  ======================  ================================= 
 d)   Aggregated             n/a (single transaction) 
       information 
       Aggregated 
       volume Price 
===  ======================  ================================= 
 e)   Date of the            2018-01-11 
       transaction 
===  ======================  ================================= 
 f)   Place of the           London Stock Exchange (XLON) 
       transaction 
===  ======================  ================================= 
 
 
 1.   Details of PDMR/person closely associated 
       with them ('PCA') 
===  ========================================================= 
 a)   Name                   Mr S Dingemans 
===  ======================  ================================= 
 b)   Position/status        Chief Financial Officer 
===  ======================  ================================= 
 c)   Initial notification/  Initial notification 
       amendment 
===  ======================  ================================= 
 2.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
===  ========================================================= 
 a)   Name                   GlaxoSmithKline plc 
===  ======================  ================================= 
 b)   LEI                    5493000HZTVUYLO1D793 
===  ======================  ================================= 
 3.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transaction(s) 
       has been conducted 
===  ========================================================= 
 a)   Description             Ordinary shares of 25 pence each 
       of the financial        ('Ordinary Shares') 
       instrument              ISIN: GB0009252882 
===  ======================  ================================= 
 b)   Nature of              Acquisition of Ordinary Shares 
       the transaction        following the re-investment of 
                              dividends paid to shareholders 
                              on 11 January 2018. 
===  ======================  ================================= 
 c)   Price(s) and             Price(s)      Volume(s) 
       volume(s)               ------------  ---------- 
                                GBP13.3440    919.518 
                               ------------  ---------- 
===  ======================  ================================= 
 d)   Aggregated             n/a (single transaction) 
       information 
       Aggregated 
       volume Price 
===  ======================  ================================= 
 e)   Date of the            2018-01-11 
       transaction 
===  ======================  ================================= 
 f)   Place of the           London Stock Exchange (XLON) 
       transaction 
===  ======================  ================================= 
 
 
 1.   Details of PDMR/person closely associated 
       with them ('PCA') 
===  ========================================================= 
 a)   Name                   Mr D S Redfern 
===  ======================  ================================= 
 b)   Position/status        Chief Strategy Officer 
===  ======================  ================================= 
 c)   Initial notification/  Initial notification 
       amendment 
===  ======================  ================================= 
 2.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
===  ========================================================= 
 a)   Name                   GlaxoSmithKline plc 
===  ======================  ================================= 
 b)   LEI                    5493000HZTVUYLO1D793 
===  ======================  ================================= 
 3.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transaction(s) 
       has been conducted 
===  ========================================================= 
 a)   Description             Ordinary shares of 25 pence each 
       of the financial        ('Ordinary Shares') 
       instrument              ISIN: GB0009252882 
===  ======================  ================================= 
 b)   Nature of              Acquisition of Ordinary Shares 
       the transaction        following the re-investment of 
                              dividends paid to shareholders 
                              on 11 January 2018. 
===  ======================  ================================= 
 c)   Price(s) and             Price(s)      Volume(s) 
       volume(s)               ------------  ---------- 
                                GBP13.3440    1552.174 
                               ------------  ---------- 
===  ======================  ================================= 
 d)   Aggregated             n/a (single transaction) 
       information 
       Aggregated 
       volume Price 
===  ======================  ================================= 
 e)   Date of the            2018-01-11 
       transaction 
===  ======================  ================================= 
 f)   Place of the           London Stock Exchange (XLON) 
       transaction 
===  ======================  ================================= 
 
 
 1.   Details of PDMR/person closely associated 
       with them ('PCA') 
===  ========================================================= 
 a)   Name                   Ms C Thomas 
===  ======================  ================================= 
 b)   Position/status        SVP, HR 
===  ======================  ================================= 
 c)   Initial notification/  Initial notification 
       amendment 
===  ======================  ================================= 
 2.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
===  ========================================================= 
 a)   Name                   GlaxoSmithKline plc 
===  ======================  ================================= 
 b)   LEI                    5493000HZTVUYLO1D793 
===  ======================  ================================= 
 3.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transaction(s) 
       has been conducted 
===  ========================================================= 
 a)   Description             Ordinary shares of 25 pence each 
       of the financial        ('Ordinary Shares') 
       instrument              ISIN: GB0009252882 
===  ======================  ================================= 
 b)   Nature of              Acquisition of Ordinary Shares 
       the transaction        following the re-investment of 
                              dividends paid to shareholders 
                              on 11 January 2018. 
===  ======================  ================================= 
 c)   Price(s) and             Price(s)      Volume(s) 
       volume(s)               ------------  ---------- 
                                GBP13.3440    599.748 
                               ------------  ---------- 
===  ======================  ================================= 
 d)   Aggregated             n/a (single transaction) 
       information 
       Aggregated 
       volume Price 
===  ======================  ================================= 
 e)   Date of the            2018-01-11 
       transaction 
===  ======================  ================================= 
 f)   Place of the           London Stock Exchange (XLON) 
       transaction 
===  ======================  ================================= 
 
 
 1.   Details of PDMR/person closely associated 
       with them ('PCA') 
===  ========================================================= 
 a)   Name                   Mr P C Thomson 
===  ======================  ================================= 
 b)   Position/status        President, Global Affairs 
===  ======================  ================================= 
 c)   Initial notification/  Initial notification 
       amendment 
===  ======================  ================================= 
 2.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
===  ========================================================= 
 a)   Name                   GlaxoSmithKline plc 
===  ======================  ================================= 
 b)   LEI                    5493000HZTVUYLO1D793 
===  ======================  ================================= 
 3.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transaction(s) 
       has been conducted 
===  ========================================================= 
 a)   Description             Ordinary shares of 25 pence each 
       of the financial        ('Ordinary Shares') 
       instrument              ISIN: GB0009252882 
===  ======================  ================================= 
 b)   Nature of              Acquisition of Ordinary Shares 
       the transaction        following the re-investment of 
                              dividends paid to shareholders 
                              on 11 January 2018. 
===  ======================  ================================= 
 c)   Price(s) and             Price(s)      Volume(s) 
       volume(s)               ------------  ---------- 
                                GBP13.3440    728.198 
                               ------------  ---------- 
===  ======================  ================================= 
 d)   Aggregated             n/a (single transaction) 
       information 
       Aggregated 
       volume Price 
===  ======================  ================================= 
 e)   Date of the            2018-01-11 
       transaction 
===  ======================  ================================= 
 f)   Place of the           London Stock Exchange (XLON) 
       transaction 
===  ======================  ================================= 
 
 
 1.   Details of PDMR/person closely associated 
       with them ('PCA') 
===  ========================================================= 
 a)   Name                   Dr P J T Vallance 
===  ======================  ================================= 
 b)   Position/status        President, R&D 
===  ======================  ================================= 
 c)   Initial notification/  Initial notification 
       amendment 
===  ======================  ================================= 
 2.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
===  ========================================================= 
 a)   Name                   GlaxoSmithKline plc 
===  ======================  ================================= 
 b)   LEI                    5493000HZTVUYLO1D793 
===  ======================  ================================= 
 3.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transaction(s) 
       has been conducted 
===  ========================================================= 
 a)   Description             Ordinary shares of 25 pence each 
       of the financial        ('Ordinary Shares') 
       instrument              ISIN: GB0009252882 
===  ======================  ================================= 
 b)   Nature of              Acquisition of Ordinary Shares 
       the transaction        following the re-investment of 
                              dividends paid to shareholders 
                              on 11 January 2018. 
===  ======================  ================================= 
 c)   Price(s) and             Price(s)      Volume(s) 
       volume(s)               ------------  ---------- 
                                GBP13.3440    2918.217 
                               ------------  ---------- 
===  ======================  ================================= 
 d)   Aggregated             n/a (single transaction) 
       information 
       Aggregated 
       volume Price 
===  ======================  ================================= 
 e)   Date of the            2018-01-11 
       transaction 
===  ======================  ================================= 
 f)   Place of the           London Stock Exchange (XLON) 
       transaction 
===  ======================  ================================= 
 
 
 1.   Details of PDMR/person closely associated 
       with them ('PCA') 
===  ========================================================= 
 a)   Name                   Mrs K Thomson 
===  ======================  ================================= 
 b)   Position/status        PCA of Mr P C Thomson (President, 
                              Global Affairs) 
===  ======================  ================================= 
 c)   Initial notification/  Initial notification 
       amendment 
===  ======================  ================================= 
 2.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
===  ========================================================= 
 a)   Name                   GlaxoSmithKline plc 
===  ======================  ================================= 
 b)   LEI                    5493000HZTVUYLO1D793 
===  ======================  ================================= 
 3.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transaction(s) 
       has been conducted 
===  ========================================================= 
 a)   Description             Ordinary shares of 25 pence each 
       of the financial        ('Ordinary Shares') 
       instrument              ISIN: GB0009252882 
===  ======================  ================================= 
 b)   Nature of              Acquisition of Ordinary Shares 
       the transaction        following the re-investment of 
                              dividends paid to shareholders 
                              on 11 January 2018. 
===  ======================  ================================= 
 c)   Price(s) and             Price(s)      Volume(s) 
       volume(s)               ------------  ---------- 
                                GBP13.3440    137.540 
                               ------------  ---------- 
===  ======================  ================================= 
 d)   Aggregated             n/a (single transaction) 
       information 
       Aggregated 
       volume Price 
===  ======================  ================================= 
 e)   Date of the            2018-01-11 
       transaction 
===  ======================  ================================= 
 f)   Place of the           London Stock Exchange (XLON) 
       transaction 
===  ======================  ================================= 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHDELFFVFFXBBF

(END) Dow Jones Newswires

January 15, 2018 12:34 ET (17:34 GMT)

Gsk (LSE:GSK)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Gsk Charts.
Gsk (LSE:GSK)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Gsk Charts.